Cargando…
IP(3)R-mediated Ca(2+) signaling controls B cell proliferation through metabolic reprogramming
Emerging evidence shows that metabolic regulation may be a critical mechanism in B cell activation and function. As targets of several most widely used immunosuppressants, Ca(2+) signaling and calcineurin may play an important role in regulating B cell metabolism. Here, we demonstrate that IP(3)R-me...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046235/ https://www.ncbi.nlm.nih.gov/pubmed/35494252 http://dx.doi.org/10.1016/j.isci.2022.104209 |
Sumario: | Emerging evidence shows that metabolic regulation may be a critical mechanism in B cell activation and function. As targets of several most widely used immunosuppressants, Ca(2+) signaling and calcineurin may play an important role in regulating B cell metabolism. Here, we demonstrate that IP(3)R-mediated Ca(2+) signaling and calcineurin regulate B cell proliferation and survival by activating metabolic reprogramming in response to B cell receptor (BCR) stimulation. Both IP(3)R-triple-knockout (IP(3)R-TKO) and calcineurin inhibition dramatically suppress the metabolic switch in oxidative phosphorylation and glycolysis of stimulated B cells through regulation of glucose uptake, glycolytic enzyme expression, and mitochondrial remodeling, leading to impaired cell-cycle entry and survival. In addition, IP(3)R-Ca(2+) acts as a master regulator of the calcineurin-MEF2C-Myc pathway in driving B cell metabolic adaptations. As genetic defects of IP(3)Rs were recently identified as a new class of inborn errors of immunity, these results have important implications for understanding the pathogenesis of such diseases. |
---|